Plasma Albumin Concentration and Diphenylhydantoin Binding in Man
- 1 May 1975
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 32 (5), 298-303
- https://doi.org/10.1001/archneur.1975.00490470042005
Abstract
The plasma protein binding of diphenylhydantoin sodium wad determined In 26 patients who had been taking diphenylhydantoin regularly for more than two weeks. The free (unbound) diphenylhydantoin level was found to vary from 5.8% to 12.6% of the total drug concentration. This range of variation may be clinically important, if it can be established that the binding of diphenylhydantoin to plasma proteins limits entry of the drug into the brain. The binding of diphenylhydantoin was directly proportional to the plasma albumin concentration, which thus appeared to be the most important determinant of diphenlhydantoin binding. Diphenylhydantoin binding was independent of the plasma concentration of the drug in the usual therapeutic range. In vitro studies showed little effect by phenobarbital sodium or penicillin G; therapeutic levels of acetylsalicylic acid, however, increased free diphenylhydantoin by nearly 50%.Keywords
This publication has 15 references indexed in Scilit:
- CHARACTERIZATION OF DRUG-PROTEIN INTERACTIONS BY CLASSIC METHODSAnnals of the New York Academy of Sciences, 1973
- THE INFLUENCE OF ACETYLSALICYLIC ACID ON THE BINDING OF ACETRIZOATE TO HUMAN ALBUMINAnnals of the New York Academy of Sciences, 1973
- Plasma protein binding of diphenylhydantoin in patients with epilepsy; Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluidClinical Pharmacology & Therapeutics, 1972
- Altered Protein Binding of Diphenylhydantoin in Uremic PlasmaNew England Journal of Medicine, 1972
- Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adultsEuropean Journal of Clinical Pharmacology, 1971
- ABNORMAL PHARMACOKINETICS OF PHENYTOIN IN A PATIENT WITH URÆMIAThe Lancet, 1970
- DIPHENYLHYDANTOIN AS AN ANTICONVULSANT: PROTEIN BINDING AND FLUCTUATION OF THE SERUM AND CEREBROSPINAL FLUID LEVELS IN FORTY MENTALLY SUBNORMAL EPILEPTICS*Journal of Intellectual Disability Research, 1969
- Potential Effect of the Plasma Proteins on Drug DistributionNature, 1965
- The Prognostic Significance of Penicillin Serum Levels and Protein Binding in Clinical Medicine. A Review of Current StudiesChemotherapy, 1965
- Studies on the metabolism of diphenylhydantoin (Dilantin)Neurology, 1961